Literature DB >> 8786991

The effect of absorption enhancers on the oral absorption of the GP IIB/IIIA receptor antagonist, DMP 728, in rats and dogs.

D L Burcham1, B A Aungst, M Hussain, M A Gorko, C Y Quon, S M Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8786991     DOI： 10.1023/a:1016289200422

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  4 in total

1.  Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonist.

Authors:  H Saitoh; B J Aungst
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 2.  Absorption enhancers: applications and advances.

Authors:  Bruce J Aungst
Journal:  AAPS J       Date:  2011-11-22       Impact factor: 4.009

3.  Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.

Authors:  M D Ribadeneira; B J Aungst; C J Eyermann; S M Huang
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.

Authors:  David Dahlgren; Markus Sjöblom; Mikael Hedeland; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2020-01-26       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.